Robust specific RBD responses and neutralizing antibodies after ChAdOx1 nCoV-19 and CoronaVac vaccination in SARS-CoV-2– seropositive individuals

Background: The pandemic unleashed by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than 500 million people worldwide and caused more than 6 million deaths. Cellular and humoral immunity induced by infection or immunization are key factors in controlling the viral bu...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Edgar Ruz Fernandes, PhD, Monica Taminato, PhD, Juliana de Souza Apostolico, PhD, Maria Cristina Gabrielonni, PhD, Victoria Alves Santos Lunardelli, PhD, Juliana Terzi Maricato, PhD, Monica Levy Andersen, PhD, Sergio Tufik, MD, PhD, Daniela Santoro Rosa, PhD
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2023-05-01
coleção:	Journal of Allergy and Clinical Immunology: Global
Assuntos:	SARS-CoV-2 COVID-19 CoronaVac ChAdOx1 nCoV-19 antibodies
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2772829323000085
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!